Premature mortality increased in adults aged 18 to 64 by 27.2% between 2012 and 2022, according to a study published in JAMA ...

National recognition from HealthMetrix Research highlights Astiva’s differentiated value, quality performance, and strategic ...

The end of the Healthy Opportunities Pilot in North Carolina is a story of how MAHA might actually be realized — or not — at ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

There’s plenty to like about the lower direct-to-consumer prices the White House negotiated with Eli Lilly and Novo Nordisk. There are also caveats and some unanswered questions.

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...

Both Lilly and Novo are racing to bring oral versions of their blockbuster GLP-1 treatments to market. Novo's once-daily oral ...

President Trump, Lilly, and Novo Nordisk agree to lower prices of GLP-1 weight-loss drugs for Medicare, Medicaid, and cash ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

We cannot allow the micromanagement of our most vulnerable citizens that places their lives and wellbeing at significant risk ...